Online citations, reference lists, and bibliographies.
← Back to Search

Extensive Skeletal Muscle Cell Mitochondriopathy Distinguishes Critical Limb Ischemia Patients From Claudicants.

T. Ryan, D. Yamaguchi, Cameron A Schmidt, Tonya N Zeczycki, S. R. Shaikh, P. Brophy, T. D. Green, Michael D Tarpey, R. Karnekar, Emma J. Goldberg, G. Sparagna, M. Torres, B. Annex, P. Neufer, E. Spangenburg, J. McClung
Published 2018 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
The most severe manifestation of peripheral arterial disease (PAD) is critical limb ischemia (CLI). CLI patients suffer high rates of amputation and mortality; accordingly, there remains a clear need both to better understand CLI and to develop more effective treatments. Gastrocnemius muscle was obtained from 32 older (51-84 years) non-PAD controls, 27 claudicating PAD patients (ankle-brachial index [ABI] 0.65 ± 0.21 SD), and 19 CLI patients (ABI 0.35 ± 0.30 SD) for whole transcriptome sequencing and comprehensive mitochondrial phenotyping. Comparable permeabilized myofiber mitochondrial function was paralleled by both similar mitochondrial content and related mRNA expression profiles in non-PAD control and claudicating patient tissues. Tissues from CLI patients, despite being histologically intact and harboring equivalent mitochondrial content, presented a unique bioenergetic signature. This signature was defined by deficits in permeabilized myofiber mitochondrial function and a unique pattern of both nuclear and mitochondrial encoded gene suppression. Moreover, isolated muscle progenitor cells retained both mitochondrial functional deficits and gene suppression observed in the tissue. These findings indicate that muscle tissues from claudicating patients and non-PAD controls were similar in both their bioenergetics profile and mitochondrial phenotypes. In contrast, CLI patient limb skeletal muscles harbor a unique skeletal muscle mitochondriopathy that represents a potentially novel therapeutic site for intervention.
This paper references
Declining walking impairment questionnaire scores are associated with subsequent increased mortality in peripheral artery disease.
A. Jain (2013)
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Bo Li (2011)
Use of Quantitative Membrane Proteomics Identifies a Novel Role of Mitochondria in Healing Injured Muscles*
Nimisha Sharma (2012)
Organelle isolation: functional mitochondria from mouse liver, muscle and cultured filroblasts
C. Frezza (2007)
Targeted Expression of Catalase to Mitochondria Protects Against Ischemic Myopathy in High-Fat Diet–Fed Mice
T. Ryan (2016)
A rapid method of total lipid extraction and purification.
E. Bligh (1959)
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
M. Robinson (2010)
How mitochondrial dynamism orchestrates mitophagy.
O. Shirihai (2015)
Mitochondrial maintenance via autophagy contributes to functional skeletal muscle regeneration and remodeling.
Anna S. Nichenko (2016)
Risk factors affecting the natural history of intermittent claudication.
M. Rosenbloom (1988)
Acquired skeletal muscle metabolic myopathy in atherosclerotic peripheral arterial disease
E. Brass (2000)
Greater Oxidative Capacity in Primary Myotubes from Endurance-trained Women
Timothy D Heden (2017)
Quantitation of cardiolipin molecular species in spontaneously hypertensive heart failure rats using electrospray ionization mass spectrometry Published, JLR Papers in Press, March 16, 2005. DOI 10.1194/jlr.M500031-JLR200
G. Sparagna (2005)
Strain-Dependent Variation in Acute Ischemic Muscle Injury.
Cameron A Schmidt (2018)
Oxidative damage and myofiber degeneration in the gastrocnemius of patients with peripheral arterial disease
D. Weiss (2013)
Protein concentration and mitochondrial content in the gastrocnemius predicts mortality rates in patients with peripheral arterial disease.
J. R. Thompson (2015)
Angiopoietin-1 enhances skeletal muscle regeneration in mice.
M. Mofarrahi (2015)
Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial
R. Lederman (2002)
Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration.
T. Rissanen (2002)
The Myopathy of Peripheral Arterial Occlusive Disease: Part 1. Functional and Histomorphological Changes and Evidence for Mitochondrial Dysfunction
I. Pipinos (2007)
Mitochondrial Regulation of the Muscle Microenvironment in Critical Limb Ischemia
T. Ryan (2015)
Basic Science Review: The Myopathy of Peripheral Arterial Occlusive Disease: Part 2. Oxidative Stress, Neuropathy, and Shift in Muscle Fiber Type
I. Pipinos (2008)
Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature. Atherosclerosis
GP Fadini (2010)
The Walking Impairment Questionnaire stair-climbing score predicts mortality in men and women with peripheral arterial disease.
A. Jain (2012)
Natural history of claudication: long-term serial follow-up study of 1244 claudicants.
R. Aquino (2001)
Bypass surgery versus endovascular interventions in severe or critical limb ischemia.
A. A. Abu Dabrh (2016)
Critical Limb Ischemia: Current Trends and Future Directions
M. Teraa (2016)
BAG3 (Bcl-2–Associated Athanogene-3) Coding Variant in Mice Determines Susceptibility to Ischemic Limb Muscle Myopathy by Directing Autophagy
J. McClung (2017)
Sarcopenia is a prognostic factor for overall survival in patients with critical limb ischemia.
Y. Matsubara (2015)
The Risk of Disease Progression in Peripheral Arterial Disease is Higher than Expected: A Meta-Analysis of Mortality and Disease Progression in Peripheral Arterial Disease.
B. Sigvant (2016)
Skeletal muscle-specific genetic determinants contribute to the differential strain-dependent effects of hindlimb ischemia in mice.
J. McClung (2012)
Effect of exercise training on skeletal muscle histology and metabolism in peripheral arterial disease.
W. Hiatt (1996)
Mitophagy and mitochondrial biogenesis in atrial tissue of patients undergoing heart surgery with cardiopulmonary bypass.
A. Andres (2017)
Satellite cells and skeletal muscle regeneration
J. Morgan (2009)
Abnormal mitochondrial respiration in skeletal muscle in patients with peripheral arterial disease.
I. Pipinos (2003)
Regulated necrotic cell death: the passive aggressive side of Bax and Bak.
J. Karch (2015)
Muscle cell derived angiopoietin-1 contributes to both myogenesis and angiogenesis in the ischemic environment
J. McClung (2015)
Decline in functional performance predicts later increased mobility loss and mortality in peripheral arterial disease.
M. McDermott (2011)
Diminished force production and mitochondrial respiratory deficits are strain‐dependent myopathies of subacute limb ischemia
Cameron A Schmidt (2017)
Exercise capacity is the strongest predictor of mortality in patients with peripheral arterial disease.
N. Leeper (2013)
Mitochondrial therapy improves limb perfusion and myopathy following hindlimb ischemia.
T. Ryan (2016)
Severe Obesity: Evidence for a Deranged Metabolic Program in Skeletal Muscle?
J. Houmard (2012)
A metabolic link to skeletal muscle wasting and regeneration
R. Koopman (2014)
Mitochondrial biogenesis during skeletal muscle regeneration.
S. Duguez (2002)
Fast gapped-read alignment with Bowtie 2
B. Langmead (2012)
Subacute limb ischemia induces skeletal muscle injury in genetically susceptible mice independent of vascular density.
J. McClung (2016)
Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature.
G. P. Fadini (2010)
Long-term survival and fate of the leg in de novo intermittent claudication
H. Kumakura (2017)
Claudication does not always precede critical leg ischemia
S. Mätzke (2001)
Chronic Changes in Skeletal Muscle Histology and Function in Peripheral Arterial Disease
J. Regensteiner (1993)
Heterogeneity of Ankle-Brachial Indices in Patients Undergoing Revascularization for Critical Limb Ischemia.
Devraj Sukul (2017)
Pyruvate dehydrogenase complex and nicotinamide nucleotide transhydrogenase constitute an energy-consuming redox circuit.
K. Fisher-Wellman (2015)
Assessment of in vivo skeletal muscle mitochondrial respiratory capacity in humans by near‐infrared spectroscopy: a comparison with in situ measurements
T. Ryan (2014)
Coordinated Metabolic Changes and Modulation of Autophagy during Myogenesis
P. Fortini (2016)
Inhibiting myosin-ATPase reveals a dynamic range of mitochondrial respiratory control in skeletal muscle.
Christopher G. R. Perry (2011)
Regional Angiogenesis With Vascular Endothelial Growth Factor in Peripheral Arterial Disease: A Phase II Randomized, Double-Blind, Controlled Study of Adenoviral Delivery of Vascular Endothelial Growth Factor 121 in Patients With Disabling Intermittent Claudication
S. Rajagopalan (2003)
Nationally Representative Readmission Factors in Patients with Claudication and Critical Limb Ischemia.
Rennier A Martinez (2018)
Leg strength predicts mortality in men but not in women with peripheral arterial disease.
N. Singh (2010)
Calf muscle characteristics, strength measures, and mortality in peripheral arterial disease: a longitudinal study.
M. McDermott (2012)
The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI).
J. Mills (2014)
Mitochondrial defects and oxidative damage in patients with peripheral arterial disease.
I. Pipinos (2006)
Peripheral artery disease, calf skeletal muscle mitochondrial DNA copy number, and functional performance
M. McDermott (2018)
In vivo and in organello assessment of OXPHOS activities.
A. Barrientos (2002)

This paper is referenced by
PFKFB3-mediated glycolysis rescues myopathic outcomes in the ischemic limb
T. Ryan (2020)
Skeletal Muscle Mitochondrial Dysfunction and Oxidative Stress in Peripheral Arterial Disease: A Unifying Mechanism and Therapeutic Target
Kyoung-Rae Kim (2020)
Altered Metabolomic Profile in Patients with Peripheral Artery Disease
Ahmed Ismaeel (2019)
Imaging in Peripheral Arterial Disease: Clinical and Research Applications
C. Kramer (2020)
Unique Transcriptome Signature Distinguishes Patients With Heart Failure With Myopathy
Talia Caspi (2020)
Imaging Needs for Development of Novel Therapeutics in PAD
Elona Rrapo Kaso (2020)
Skeletal muscle expression of adipose-specific phospholipase in peripheral artery disease
Caitlin Parmer (2020)
Fibrosis Distinguishes Critical Limb Ischemia Patients from Claudicants in a Transcriptomic and Histologic Analysis
Guangzhi Cong (2020)
Utilization of biomarkers as predictors of skeletal muscle mitochondrial content after physiological intervention and in clinical settings.
T. Groennebaek (2020)
Uremic metabolites impair skeletal muscle mitochondrial energetics through disruption of the electron transport system and matrix dehydrogenase activity.
Trace Thome (2019)
Nationally Representative Readmission Factors in Patients with Claudication and Critical Limb Ischemia.
Rennier A Martinez (2018)
Sarcopenia and peripheral arterial disease: a systematic review
Mégane Pizzimenti (2020)
Mitochondrial Structure and Function in the Metabolic Myopathy Accompanying Patients with Critical Limb Ischemia
T. Groennebaek (2020)
Haploinsufficiency of Transferrin Receptor 1 Impairs Angiogenesis with Reduced Mitochondrial Complex I in Mice with Limb Ischemia
Keisuke Okuno (2019)
Skeletal Muscle Pathology in Peripheral Artery Disease: A Brief Review.
M. McDermott (2020)
Mitochondrial DNA damage in calf skeletal muscle and walking performance in people with peripheral artery disease.
S. Saini (2020)
Chronic kidney disease exacerbates ischemic limb myopathy in mice via altered mitochondrial energetics
Fabian N Berru (2019)
Temporal Association Between Ischemic Muscle Perfusion Recovery and the Restoration of Muscle Contractile Function After Hindlimb Ischemia
Emma J. Goldberg (2019)
Exercise enhances mitochondrial fission and mitophagy to improve myopathy following critical limb ischemia in elderly mice via the PGC1a/FNDC5/irisin pathway
Wuyang He (2020)
Semantic Scholar Logo Some data provided by SemanticScholar